Calcium Acetate Tablet
NDC Package 62135-192-22
Package Information
Calcium Acetate tablets is calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). This formulation utilizes a tablet delivery system. Marketed by Chartwell Rx Llc, this product is identified by NDC 62135-192 and is authorized under FDA application ANDA202420.
Identification & Billing
- RxCUI: 197433 - calcium 169 MG Oral Tablet, as calcium acetate
- RxCUI: 197433 - calcium acetate 667 MG Oral Tablet
- RxCUI: 197433 - calcium acetate 667 MG (calcium 169 MG) Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 62135 - Chartwell Rx Llc
- 62135-192 - Calcium Acetate
- 62135-192-22 - 200 TABLET in 1 BOTTLE
- 62135-192 - Calcium Acetate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62135-192-22 identifies a specific commercial package of 200 tablet in 1 bottle of Calcium Acetate, a human prescription drug labeled by Chartwell Rx Llc. This tablet is formulated for oral use and contains calcium acetate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chartwell Rx Llc on July 01, 2019. The current certification is valid through December 31, 2026.
How is this Chartwell Rx Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62135019222. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 200 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.